The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

BACKGROUND: The management of pT1a-b pN0 HER2-positive breast cancer is controversial and no data about the efficacy of trastuzumab in this setting are available from randomized clinical trials. The aims of this retrospective study were to assess how patients are managed in clinical practice in Ital...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Stefania, Inno, Alessandro, Fiorio, Elena, Foglietta, Jennifer, Ferro, Antonella, Gulisano, Marcella, Pinotti, Graziella, Gubiotti, Marta, Cavazzini, Maria Giovanna, Turazza, Monica, Duranti, Simona, De Simone, Valeria, Iezzi, Laura, Bisagni, Giancarlo, Spazzapan, Simon, Cavanna, Luigi, Saggia, Chiara, Bria, Emilio, Cretella, Elisabetta, Vici, Patrizia, Santini, Daniele, Fabi, Alessandra, Garrone, Ornella, Frassoldati, Antonio, Amaducci, Laura, Saracchini, Silvana, Evangelisti, Lucia, Barni, Sandro, Gamucci, Teresa, Mentuccia, Lucia, Laudadio, Lucio, Zoboli, Alessandra, Marchetti, Fabiana, Bogina, Giuseppe, Lunardi, Gianluigi, Boni, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560419/
https://www.ncbi.nlm.nih.gov/pubmed/26340098
http://dx.doi.org/10.1371/journal.pone.0136731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560419/
https://www.ncbi.nlm.nih.gov/pubmed/26340098
http://dx.doi.org/10.1371/journal.pone.0136731

Ejemplares similares